These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31403827)

  • 1. Interleukin-11 Overexpression and M2 Macrophage Density are Associated with Angiogenic Activity in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Ahmad A; Allegaert E; Siddiquei MM; Gikandi PW; De Hertogh G; Opdenakker G
    Ocul Immunol Inflamm; 2020 May; 28(4):575-588. PubMed ID: 31403827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD146/Soluble CD146 Pathway Is a Novel Biomarker of Angiogenesis and Inflammation in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ahmad A; Siddiquei MM; Allegaert E; Gikandi PW; De Hertogh G; Opdenakker G
    Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):32. PubMed ID: 34293080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-1 studies in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Allegaert E; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
    Acta Ophthalmol; 2020 Feb; 98(1):e1-e12. PubMed ID: 31318490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated Expression of Heparanase in the Vitreous of Patients With Proliferative Diabetic Retinopathy Originates From Activated Endothelial Cells and Leukocytes.
    Abu El-Asrar AM; Alam K; Nawaz MI; Mohammad G; Van den Eynde K; Siddiquei MM; Mousa A; De Hertogh G; Geboes K; Opdenakker G
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8239-47. PubMed ID: 26720478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of Thrombin/Matrix Metalloproteinase-1/Protease-Activated Receptor-1 Chain in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Alam K; Nawaz MI; Mohammad G; Van den Eynde K; Siddiquei MM; Mousa A; De Hertogh G; Opdenakker G
    Curr Eye Res; 2016 Dec; 41(12):1590-1600. PubMed ID: 27261371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
    Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: implications for M2 macrophage-involving fibrovascular membrane formation.
    Yoshida S; Kobayashi Y; Nakama T; Zhou Y; Ishikawa K; Arita R; Nakao S; Miyazaki M; Sassa Y; Oshima Y; Izuhara K; Kono T; Ishibashi T
    Br J Ophthalmol; 2015 May; 99(5):629-34. PubMed ID: 25355804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Alam K; Siddiquei MM; Mohammad G; Hertogh G; Mousa A; Opdenakker G
    Acta Ophthalmol; 2017 Nov; 95(7):697-704. PubMed ID: 27860331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of thrombospondin-2 as a marker in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ola MS; De Hertogh G; Opdenakker G; Geboes K
    Acta Ophthalmol; 2013 May; 91(3):e169-77. PubMed ID: 23387388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
    Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
    Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Struyf S; Mohammad G; Gouwy M; Rytinx P; Siddiquei MM; Hernández C; Alam K; Mousa A; De Hertogh G; Opdenakker G; Simó R
    Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3189-3201. PubMed ID: 28654984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of CD163 in vitreous and fibrovascular membranes of patients with proliferative diabetic retinopathy: possible involvement of periostin.
    Kobayashi Y; Yoshida S; Nakama T; Zhou Y; Ishikawa K; Arita R; Nakao S; Miyazaki M; Sassa Y; Oshima Y; Izuhara K; Kono T; Ishibashi T
    Br J Ophthalmol; 2015 Apr; 99(4):451-6. PubMed ID: 25281471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Mohammad G; Allegaert E; Ahmad A; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
    Mol Vis; 2018; 24():394-406. PubMed ID: 29853773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression and localization of human tissue inhibitors of metalloproteinases in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
    Acta Ophthalmol; 2018 Feb; 96(1):e27-e37. PubMed ID: 28391660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor, and MMP-9 in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Siddiquei MM; Nawaz MI; De Hertogh G; Mohammad G; Alam K; Mousa A; Opdenakker G
    Mol Vis; 2016; 22():424-35. PubMed ID: 27168718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-Myofibroblast Transition Contributes to Myofibroblast Formation in Proliferative Vitreoretinal Disorders.
    Abu El-Asrar AM; De Hertogh G; Allegaert E; Nawaz MI; Abouelasrar Salama S; Gikandi PW; Opdenakker G; Struyf S
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor necrosis factor superfamily members TWEAK, TNFSF15 and fibroblast growth factor-inducible protein 14 are upregulated in proliferative diabetic retinopathy.
    Abu El-Asrar AM; De Hertogh G; Nawaz MI; Siddiquei MM; Van den Eynde K; Mohammad G; Opdenakker G; Geboes K
    Ophthalmic Res; 2015; 53(3):122-30. PubMed ID: 25676319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Proteoforms of the Transmembrane Chemokines CXCL16 and CX3CL1, Their Receptors, and Their Processing Metalloproteinases ADAM10 and ADAM17 in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Nawaz MI; Ahmad A; De Zutter A; Siddiquei MM; Blanter M; Allegaert E; Gikandi PW; De Hertogh G; Van Damme J; Opdenakker G; Struyf S
    Front Immunol; 2020; 11():601639. PubMed ID: 33552057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unbalanced Vitreous Levels of Osteoprotegerin, RANKL, RANK, and TRAIL in Proliferative Diabetic Retinopathy.
    Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
    Ocul Immunol Inflamm; 2018; 26(8):1248-1260. PubMed ID: 28914577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of Cyr61 induced degeneration of human Müller cells in diabetic retinopathy.
    Zhou F; Zhang Y; Chen D; Su Z; Jin L; Wang L; Hu Z; Ke Z; Song Z
    PLoS One; 2014; 9(10):e109418. PubMed ID: 25329584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.